ACADIA Pharmaceutical’s $52.5 Million Acquisition of CerSci Therapeutics

Skadden, Arps, Slate, Meagher & Flom LLP advised CerSci Therapeutics on the deal. Paul Hastings, LLP acted as legal advisor to ACADIA ACADIA Pharmaceuticals Inc. (Nasdaq:…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Ambrogio Visconti

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here